Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report

Am J Hematol. 2016 Feb;91(2):E1. doi: 10.1002/ajh.24225.

Authors

Maria Rubinstein¹, Amer Assal^{1

2}, Marina Scherba³, Jordan Elman², Robert White⁴, Amit Verma^{1

2}, Marianna Strakhan^{2

5}, Farnoush Mohammadi^{2

5}, Murali Janakiram^{1

2}

Affiliations

¹ Montefiore Medical Center, New York.
² Albert Einstein College of Medicine, New York.
³ Memorial Sloan Kettering Cancer Center, New York.
⁴ Weill Cornell Medical Center, New York.
⁵ Jacobi Medical Center, New York.

PMID: 26502013
DOI: 10.1002/ajh.24225

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Histiocytosis, Sinus / diagnosis
Histiocytosis, Sinus / drug therapy*
Histiocytosis, Sinus / immunology
Humans
Immunologic Factors / administration & dosage
Immunologic Factors / therapeutic use*
Lenalidomide
Male
Thalidomide / administration & dosage
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use
Treatment Outcome

Substances

Immunologic Factors
Thalidomide
Lenalidomide